Summary
The product MAST P 100 Drostanolone Propionate 100mg/ml, manufactured by Unique Pharma, was independently tested to verify its authenticity and potency. The sample, identified by batch number UN55447 exp 03/2026, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Drostanolone Propionate, with a concentration of 112.54 mg/ml, exceeding the labeled claim of 100 mg/ml by 12.54%.
The testing process commenced on 18 June 2024, with the sample received on 20 June 2024, and the analysis completed on 21 June 2024. While the results confirm that the product slightly exceeds the stated concentration, it is important to consider that reseller-submitted samples may represent high-quality batches that do not necessarily reflect overall market consistency. Independent third-party testing remains essential to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: MAST P 100 Drostanolone Propionate 100mg/ml
- Active Ingredient: Drostanolone Propionate
- Batch Number: UN55447 exp 03/2026
- Expiration Date: March 2026
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #44210
- Testing Ordered: 18 June 2024
- Sample Received: 20 June 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 112.54 mg/ml
- Accuracy: 112.54% (12.54% above the label claim)
- Variance: +12.54%
Verification Details
- Verification URL: [Click Here to View]
- Originally Published: [Click Here to View]
Evaluation of Reseller-Submitted Testing
This analysis confirms that the tested product slightly exceeds its labeled claim. However, since the sample was submitted and funded by the reseller Opitropin.EU, there is a possibility that high-quality batches were selectively chosen for analysis. To ensure a comprehensive understanding of the product’s consistency, further third-party testing across multiple batches is recommended.
Conclusion
The analysis of MAST P 100 Drostanolone Propionate 100mg/ml confirms a measured concentration of 112.54 mg/ml, reflecting a slight overdose. This suggests strong quality control for this batch; however, the observed variance highlights the need for additional testing to ensure consistent dosing across production batches. This report aims to support educational and harm reduction efforts, helping consumers make informed choices.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce inherent biases; however, it still provides useful insights when critically assessed alongside independent third-party results. Readers are encouraged to use this information responsibly.
